SECsense Logo

InterCure Ltd. Financial Report: December 2024 Insights & Upcoming Shareholder Meeting

$INCR
Form 6-K
Filed on: 2024-12-20
Source
InterCure Ltd. Financial Report: December 2024 Insights & Upcoming Shareholder Meeting

Here are the key insights extracted from the provided section of the financial report relating to InterCure Ltd.:

  1. Filing Type: This document is a Form 6-K, which is typically used by foreign companies to report certain material information to the SEC.
  2. Company Information:
  • Company Name: InterCure Ltd.
  • Address: 85 Medinat ha-Yehudim Street, Herzliya, 4676670, Israel.
  • Contact: Tel: +972 77 460 5012.
  1. Reporting Period: The report is submitted for the month of December 2024.
  2. Extraordinary General Meeting:
  • Date and Time: The Extraordinary General Meeting of Shareholders is scheduled for January 27, 2025, at 4:00 p.m. (Israel time).
  • Location: The meeting will take place at the offices of the Company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, located in Bnei Brak, Israel.
  1. Meeting Agenda:
  • The report includes a notice and proxy statement detailing proposals to be voted upon during the meeting. The notice and proxy statement are attached as Exhibit 99.1.
  • A proxy card for shareholders to vote without attending in person is also provided and attached as Exhibit 99.2.
  1. Regulatory Compliance: The filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
  2. Signatory Information: The report is signed by Amos Cohen, the Chief Financial Officer, affirming its authenticity.

This information indicates that InterCure Ltd. is actively engaging with its shareholders and complying with regulatory requirements while preparing for its upcoming Extraordinary General Meeting. The details provided in the notice and proxy statement will be crucial for shareholders in understanding the proposals and voting procedures.